1. Acknowledgement to Referees

   Acknowledgement 14 November 2022 Pages: 1021 - 1024

2. SGLT2 Inhibitors Improve Cardiac Failure by Reducing Whole-Body Oxygen Demand: A Hypothesis

   • Takeshi Onoue
   • Masaharu Kataoka

   Current Opinion 07 November 2022 Pages: 1025 - 1030

   

3. The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

   • Mohamed Abuelazm
   • Ahmed Ghanem
   • Basel Abdelazeem

   Systematic Review Open access 31 October 2022 Pages: 1031 - 1047

   

4. Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

   • Devarapalli Ranjani Durga
   • Nadella Mounika
   • Ramu Adela

   Systematic Review 04 November 2022 Pages: 1049 - 1064

   

5. COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study

   • Francesco Ferrara
   • Carolina Mancaniello
   • Antonio Vitiello

   Original Research Article 23 October 2022 Pages: 1065 - 1074

   

6. Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated Thrombosis

   • Young Eun Shin
   • Arun Kumar
   • Wenchen (Kenneth) Wu

   Original Research Article 31 October 2022 Pages: 1075 - 1083

   

7. Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US

   • Buthainah Ghanem
   • Lu Shi

   Original Research Article 01 November 2022 Pages: 1085 - 1092

   

8. Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects

   • Mikkel Askjær Agersnap
   • Kim Sonne
   • Mark Berner-Hansen

   Original Research Article Open access 02 November 2022 Pages: 1093 - 1100

   

9. Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability Studies

   • Nicolas Atrux-Tallau
   • Zulaikha Naimi
   • Eric-Olivier Jaudinot

   Original Research Article Open access 04 November 2022 Pages: 1101 - 1112

   

10. Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D₂-Based Pharmacological Class Effect Query Defined by FAERS

    • Seth C. Hopkins
    • Ajay Ogirala
    • Kenneth S. Koblan

    Original Research Article Open access 09 November 2022 Pages: 1113 - 1121